期刊文献+

尿微量蛋白四项联检对非糖尿病高血压肾损伤的早期诊断价值 被引量:2

Value of the Combination Detection of Four Urine Micro-proteins in Early Diagnosis of Non-diabet- ic Hypertensive Renal Damage
下载PDF
导出
摘要 目的 探讨尿微量蛋白中尿微量白蛋白(mAlb)、尿转铁蛋白(TRF)、尿α1微球蛋白(α1‐MG)、尿免疫球蛋白(Ig G )四项联检对非糖尿病高血压肾损伤早期诊断价值。方法 通过分别对确诊非糖尿病高血压100例患者(观察组)和100例健康体检者(对照组)尿液进行尿微量蛋白四项进行检测,血液进行生化检测,并对检测结果进行统计学分析。结果 观察组尿微量蛋白高于对照组,mAlb阳性为35例(35%),TRF阳性为24例(24%),α1‐M G阳性为32例(32%),IgG阳性为15例(15%),四项联合检测的阳性率为55%,观察组高血压、肥胖、高C反应蛋白,低高密度脂蛋白与尿微量蛋白有相关性。结论 mAlb、TRF、α1‐MG、IgG联检能提高非糖尿病高血压肾损伤的早期诊断率。 Objective] To explore the value of the combination detection of four urine micro‐proteins urine trace albumin(mAlb) ,urinary transferrin(TRF) ,urine alpha 1 microglobulin(α1‐MG) and urine immunoglobulin (IgG) in early diagnosis of non‐diabetic hypertensive renal injury .[Methods]Four urine micro‐proteins of 100 pa‐tients confirmed as non‐diabetic hypertension(observation group) and 100 healthy physical examination persons (control group) were examined .Blood biochemical indicators were detected .The test results were analyzed statis‐tically .[Results] Urine micro‐proteins in observation group were higher than those in control group .The mAlb in 35 patients(35% ) ,TRF in 24 patients(24% ) ,α1‐MG in 32 patients(32% ) and IgG in 15 patients(15% ) were positive .The positive rate of the combination detection of four micro‐proteins was 55% .Hypertension ,obesity , high CRP ,low and high‐density lipoproteins in observation group had correlation with urine micro‐proteins .[Con‐clusion] The combination detection of mAlb ,TRF ,α1‐MG and IgG can improve early diagnostic rate of non‐dia‐betic hypertensive renal injury .
作者 杨玉霞
出处 《医学临床研究》 CAS 2014年第11期2206-2208,共3页 Journal of Clinical Research
关键词 蛋白尿 高血压/并发症 肾疾病/病因学 肾疾病/诊断 早期诊断 Proteinuria Hypertension/CO Kidney Diseases/ET Kidney Diseases/DI Early Diag-nosis
  • 相关文献

参考文献6

二级参考文献20

  • 1杨勇,谢兵德,黄田海,张晋静,王国富,张国华.高血压病患者早期肾损害的指标观察[J].宁夏医学杂志,2004,26(8):469-471. 被引量:4
  • 2乔玉峰,庞东梓,张志利,蒋云生.糖尿病肾病早期诊断指标研究进展[J].国外医学(泌尿系统分册),2005,25(5):670-673. 被引量:13
  • 3孙艳虹,曾智杰,姜傥,高玲,罗美如,范敏珊.血清半胱氨酸蛋白酶抑制剂C在肾病患者肾功能评估中的应用[J].中华肾脏病杂志,2006,22(8):503-504. 被引量:35
  • 4马建林,曾广民.高血压合理治疗答疑[M].北京:人民军医出版社,2007:13-54.
  • 5Chalmem J, MacMahon S, Mancia G,et al. 1999 world health organization-lnternational society of hypertension guidelines for the management Of hypertension. Guidelines sub-committee of the World Health Organization [J]. Clin Exp Hypertens, 1999 ;21 ( 5-6 ) : 1009-60.
  • 6Klag M J, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in man[J]. N Engl J Med,1996 ;334 :13-9.
  • 7Wu JT. Advanced glycosylation end products : a new disease marker for diabetes and aging[J]. Clin Lab Anal, 1993 ;7:252-5.
  • 8Uslu S, Efe B, Alatas O, et al. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients[J]. J Neph- rol,2005 ;18(5) :559-67.
  • 9Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C [ J ]. Kidney Int,2004 ;66:1115-22.
  • 10Watanabe S,Okura T,Liu J,et aL Serum eystain C level is a marker of endorgan damage in patients with essential hy- pertension[ J ]. Hypertens Res,2003,26( 11 ) :1674 - 1677.

共引文献192

同被引文献23

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部